跳至主要内容
临床试验/ISRCTN88729946
ISRCTN88729946已完成不适用

Treatment of acute hepatitis C infection: immediate therapy of all patients with peg-interferon alpha-2b alone versus delayed therapy of patients not eliminating hepatitis C virus (HCV) spontaneously with peg-interferon alpha-2b plus ribaviri

Hannover Medical School (Medizinische Hochschule Hannover) (Germany)0 个研究点目标入组 135 人开始时间: 2005年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with acute HCV infection and detectable HCV RNA
  • 2. More than 18 years
  • 3. Compensated liver disease
  • 4. Negative urine or blood pregnancy test
  • 5. Willingness to give written informed consent

排除标准

  • 1. Other possible reasons for acute HCV infection
  • 2. Liver cirrhosis
  • 3. Pregnancy or breast feeding
  • 4. Previous antiviral therapy with interferon or ribavirin
  • 5. Positive test results for anti hepatitis A virus (HAV) IgM antib., HBsAg, anti-HBc IgM antib., HBeAg, anti human immunodeficiency virus (HIV)
  • 6. History or evidence for chronic liver disease
  • 7. History of severe psychiatric disease, thyroid dysfunction poorly controlled
  • 8. History or evidence for severe illness
  • 9. Drug use within 6 mionths prior to first dose of study drug

研究者

发起方
Hannover Medical School (Medizinische Hochschule Hannover) (Germany)

相似试验